LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...

Reported positive results from potentially registrational Phase 2 trial ofLB-102 in schizophreniaAdvanced LB-102 into late-stage development in ...

Scientists have long-studied the role of dopamine, a chemical in the brain that helps control learning and movement, in order ...

As your parents get older and you become their caregiver, you may be caught off guard by an unexpected health problem they develop: mental illness. New cases of depression, anxiety or substance ...

How does dopamine control both movement and learning? New research reveals that acetylcholine acts as a "switch" for dopamine ...

LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S. NOVA-2 trial to enroll approximately ...

UCSF scientists are in a tight race against time, trying to spot telltale brain signals before a person’s first psychotic ...

Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to ...